J. D. Finley's Insider Trades & SAST Disclosures
J. D. Finley's most recent trade in Palisade Bio Inc was a trade of 47,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 11, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern J. D. Finley.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 47,000 | 47,000 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,335 | 12,927 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,335 | 0 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 2,111 | 14,079 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 2,111 | 0 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 1,622 | 10,059 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 1,622 | 0 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 28 May 2024 | 959 | 11,968 | - | 4.8 | 4,565 | Common Stock, par value $0.01 |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 28 May 2024 | 607 | 13,472 | - | 4.8 | 2,889 | Common Stock, par value $0.01 |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 28 May 2024 | 467 | 9,592 | - | 4.8 | 2,223 | Common Stock, par value $0.01 |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Purchase of securities on an exchange or from another person at price $ 4.81 per share. | 24 May 2024 | 1,000 | 8,437 | - | 4.8 | 4,810 | Common Stock, par value $0.01 |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Grant, award, or other acquisition of securities at price $ 4.97 per share. | 20 May 2024 | 666 | 7,437 | - | 5.0 | 3,312 | Common Stock, par value $0.01 |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 232 | 6,688 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 232 | 1,622 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 211 | 6,832 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 211 | 2,111 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.46 per share. | 06 May 2024 | 67 | 6,621 | - | 8.5 | 567 | Common Stock, par value $0.01 |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.46 per share. | 06 May 2024 | 61 | 6,771 | - | 8.5 | 516 | Common Stock, par value $0.01 |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 5,558 | 96,849 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 5,558 | 50,025 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Purchase of securities on an exchange or from another person at price $ 0.47 per share. | 06 Feb 2024 | 10,000 | 84,649 | - | 0.5 | 4,692 | Common Stock, par value $0.01 |
| Palisade Bio Inc | D. Finley J. | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 3,475 | 27,800 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | D. J. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 3,475 | 88,124 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | D. Finley J. | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 3,167 | 34,833 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | Finley J. D. | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 3,167 | 91,291 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 31 Jan 2024 | 10,000 | 74,649 | - | 0.6 | 5,590 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Finley D. J. | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 1,309 | 0 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | Finley D. J. | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 1,309 | 64,649 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | D. J. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2023 | 5,559 | 55,583 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | Finley J. D. | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2023 | 5,559 | 63,340 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2023 | 3,475 | 11,057 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2023 | 3,475 | 34,750 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.70 per share. | 06 Aug 2023 | 1,040 | 9,628 | - | 0.7 | 728 | Common Stock, par value $0.01 |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2023 | 1,309 | 2,618 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2023 | 1,309 | 7,582 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.76 per share. | 03 Jul 2023 | 389 | 7,193 | - | 1.8 | 686 | Common Stock, par value $0.01 |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2023 | 148,500 | 148,500 | - | - | Common Stock Options | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2023 | 66,700 | 66,700 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 1,309 | 3,927 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 1,309 | 4,283 | - | 0 | Common Stock, par value $0.01 | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.01 per share. | 03 Apr 2023 | 435 | 3,848 | - | 2.0 | 874 | Common Stock, par value $0.01 |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 57,200 | 57,200 | - | - | Common Stock Purchase Option | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 41,700 | 41,700 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | J. D. Finley | Director, CEO, CFO, Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 32,500 | 32,500 | - | - | Restricted Performance Stock Units | |
| Palisade Bio Inc | J. D. Finley | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 5,236 | 5,236 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | J. D. Finley | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.16 per share. | 23 Aug 2022 | 7,350 | 129,246 | - | 0.2 | 1,176 | Common Stock, par value $0.01 |
| Palisade Bio Inc | J. D. Finley | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 16 Aug 2022 | 100,000 | 121,896 | - | 0.3 | 25,000 | Common Stock, par value $0.01 |
| Palisade Bio Inc | J. D. Finley | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Aug 2022 | 100,000 | 100,000 | - | - | Series 1 Common Stock Purchase Warrant | |
| Palisade Bio Inc | J. D. Finley | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Aug 2022 | 100,000 | 100,000 | - | - | Series 2 Common Stock Purchase Warrant | |
| Palisade Bio Inc | J. D. Finley | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 29 Apr 2022 | 12,545 | 38,867 | - | 0 | Common Stock | |
| Palisade Bio Inc | J. D. Finley | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.09 per share. | 24 Mar 2022 | 7,500 | 21,896 | - | 1.1 | 8,174 | Common Stock |
| Palisade Bio Inc | J. D. Finley | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 64,800 | 64,800 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges